Small Cell Ovarian Cancer Foundation Inc (EIN 273940238) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2010

Legal Domicile

Principal Officer

Deirdre M Petersen

Phone

8015586515

Tax Period

2025-01-01 to 2025-12-31

Small Cell Ovarian Cancer Foundation Inc, founded in 2010, is a small nonprofit in the Human Services sector that reported $115K in total revenue in fiscal year 2025. Revenue fell 65% from the prior year — a significant decline worth monitoring. The organization ran a surplus of $67K, a strong 58% operating margin.

Mission

The Small Cell Ovarian Cancer Foundation was formed in 2010. Our mission is to fund research, raise awareness and provide information on Small Cell Carcinoma of the Ovary, Hypercalcemic Type

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2025)

Revenue Breakdown

Contributions & Grants $76,603

Program Service Revenue $0

Investment Income $38,084

Other Revenue $0

TOTAL REVENUE $114,687

Expense Breakdown

Grants Paid $37,147

Salaries & Benefits $0

Fundraising Expenses $3,640

Program Expenses $43,410

Other Expenses $10,474

TOTAL EXPENSES $47,621

Year-over-Year Comparison

	2025	2024	Change
Revenue	$114,687	$329,572	-0.7%
Expenses	$47,621	$114,190	-0.6%
Net Income	$67,066	$215,382	-0.7%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✓ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Deirdre Maren Petersen	Director	010.00	Officer Director	$0	$0	$0
Ronald James Petersen	Director	001.00	Officer Director	$0	$0	$0
Gregory J Petersen	Director	000.50	Officer Director	$0	$0	$0
Christeen M Petersen	Director	000.50	Officer Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$114,687	$47,621	$1,103,713	$67,066
2024	$329,572	$114,190	$1,036,647	$215,382
2023	$492,304	$219,464	$821,265	$272,840
2022	$398,968	$11,171	$548,425	$387,797

Small Cell Ovarian Cancer Foundation Inc